Royal Philips has received 510(k) clearance from the FDA for its Ingenia Elition 3.0T MR solution and two clinical applications, Philips Compressed SENSE and 3D APT. This integrated suite of innovations enables clinicians to perform exams faster, increase diagnostic confidence and improve the patient experience. The first commercial installation of the Philips Ingenia Elition in the U.S. has recently been completed at Hennepin Healthcare, a comprehensive health care system in Minneapolis.
“Together, the Ingenia Elition and our new clinical applications make producing high-quality images fast and easy, enabling prompt diagnosis and setting the stage for effective treatment,” said Arjen Radder, global business leader for MR at Philips. “We’re receiving a strong positive reaction from our customers as we continue to roll out our all-new Ingenia digital MR portfolio. It’s providing health care organizations like Hennepin Health with innovative solutions that seamlessly connect data, technology and people to drive the highest quality of care.”
“To deliver fast, consistent and accurate diagnoses, our staff need to be supported with technology that gives them the ability to provide the best patient care, in an efficient and cost-effective way,” said Dr. Chip Truwit, MD, Chair, Radiology, Hennepin Healthcare. “Philips’ Ingenia Elition plays a critical role in elevating the standard of care for our patients in imaging and in improving overall operations in our new imaging center.”
The Ingenia Elition is part of Philips’ all-new Ingenia digital MR portfolio, which supports radiology departments to enhance productivity, improving the patient and staff experience, while delivering better value-based care through improved patient outcomes at lower costs. In addition to receiving U.S. FDA approval the Ingenia Elition 3.0T is also available for sale in Europe.